The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10366 malaria professionals are enjoying the free benefits of MalariaWorld today

Last week at MalariaWorld: Personal message

March 26, 2020 - 17:47 -- Ingeborg van Schayk

Personal Message

We are all in an unprecedented and unpredictable situation. For those of you who are effortlessly working in the health sector to take care of patients, family and friends, we so much respect and appreciate the work you are doing.

These are uncertain times. We worry about the health of our kids, our family, ourselves, our friends, our neighbours and colleagues. Whilst focussing on controlling the corona virus we continue to fight against malaria as well.

We wish you all the strength you need to stay healthy and stay safe.

Please take care of one another.

Warm regards on behalf of the entire MalariaWorld team,


Message from WHO

WHO urges countries to ensure the continuity of malaria services in the context of the COVID-19 pandemic
The COVID-19 pandemic is testing the resilience of robust health systems around the world. Recognizing the heavy toll that malaria exacts on vulnerable populations in sub-Saharan Africa, as well as the region’s fragile health infrastructure, WHO underlines the critical importance of sustaining efforts to prevent, detect and treat malaria... Read more


New from MESA

ASTMH 2019 Recap in the MESA Resouce Hub: Routine Data for Decision-Making: Driving Progress in Malaria Control
Watch the presentations from this symposium, in which experts from three different African countries (Mozambique, Tanzania and Zambia) highlighted innovative initiatives across diverse setting to use routine data for decision-making... Watch these publications

Share your vacancies, events and news on MalariaWorld

Advertise your vacancies, events and news on MalariaWorld
and reach 10.000+ malaria professionals in 140 countries.


This weeks Malaria Minute Podcast

Chloroquine Considered as Potential Treatment for COVID-19
Scientists evaluate chloroquine as a potential treatment for the coronavirus and, as it continues to spread around the world, a report in The Lancet stresses the need for preparedness in malaria-endemic regions... Listen to this Podcast

Global Malaria News

Nevada governor limits use of anti-malaria drugs for coronavirus patients
CNN, 25 March 2020
Nevada's governor has signed an emergency regulation limiting the use of two anti-malaria drugs to treat coronavirus patients, the same medication that President Donald Trump has touted as possible treatments. Trump has said that using chloroquine and hydroxychloroquine as treatments for coronavirus could be "one of the biggest game changers in the history of medicine," and mistakenly said the drugs had been approved for treatment... Read more


Coronavirus and chloroquine: Has its use been approved in US?
BBC, 21 March 2020
President Trump claims a drug used against malaria has been approved in the United States to treat the new coronavirus. However, the FDA has made it clear it has not been approved for treating those infected with the Covid-19 coronavirus... Read more

Subscribe to the Newsletter

 Receive MalariaWorld news by email newsletter



Scientific Publications

During the past week new scientific malaria publications were published on MalariaWorld

Read the latest scientific malaria publications here

Enjoy this week's MalariaWorld - the MW team

Support MalariaWorld with your donation

Do you appreciate MalariaWorld?

Help us to keep going and provide Open Access to malaria information for all. 
We will use your donation solely to further develop MalariaWorld.


or contact us as

MalariaWorld is a project of the Dutch Malaria Foundation, a charitable, registered, not-for-profit organisation

Log in at MalariaWorld. Remember that you have to log-in at MW to read more, respond to polls, open attachments and get free copies of books and other documents. Forgot your username and/or password? Go to, click on Sign in and then on Request new password. Fill out your email address that you use to receive the MW newsletter and the Word verification. You will then receive further instructions by email.